Improved Health Markers : Lower blood sugar levels, reduced cholesterol, and better blood pressure
Not medical advice
These are often dose-related and may improve with slower dose escalation, hydration, fiber, protein planning, and individualized adjustments
2022 DOI: 10.1016/j.cmet.2022.07.013 PMID: 35985340 Read on PubMed The Lancet LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Urva S, Coskun T, Loh MT, et al
With physician-guided treatment, most patients see steady weight loss within a few months but your exact timeline depends on your starting point, dose, and consistency
Nystrom, T